The UC Davis Psychedelic Summit brought together national experts to explore what the rapidly evolving field of psychedelics and neurotherapeutics may mean for neuropsychiatric and neurodegenerative diseases. These new treatment types may hold promise for anxiety, depression, substance use, obsessive-compulsive and post-traumatic stress disorders, among others. The event was hosted by the UC Davis Department of Psychiatry and Behavioral Sciences, the UC Davis Institute for Psychedelics and Neurotherapeutics, and the UC Davis Behavioral Health Center for Excellence.

Watch more lectures from this conference: https://youtube.com/playlist?list=PLM7qvIv8N9RuTdLd7xOa7FoTM3bVsahte
Learn more about the Psychedelic Summit at UC Davis: https://health.ucdavis.edu/news/headlines/top-psychedelic-researchers-featured-in-new-video-series/2023/06
UC Davis Department of Psychiatry and Behavioral Sciences: https://health.ucdavis.edu/psychiatry/
UC Davis Institute for Psychedelics and Neurotherapeutics: https://neurotherapeutics.ucdavis.edu/
UC Davis Behavioral Health Center for Excellence: https://behavioralhealth.ucdavis.edu
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom

The information in this video was accurate as of the upload date, 5/13/23. For information purposes only. Consult your local medical authority for advice.

#Neurotherapeutics #psychedelic #ucdavis

" />
Like0000000or copy the linkDavid Olson, Ph.D., Director of the UC Davis Institute for Psychedelics and Neurotherapeutics, discusses “Psychedelics and Plasticity-Promoting Neurotherapeutics.” The lecture was recorded March 23, 2023, at the Psychedelic Summit on the UC [More]
Like0000000or copy the linkJosh Woolley, M.D., Ph.D., associate professor of psychology at UC San Francisco (@ucsf), discusses the topic “Researching Psilocybin Therapy: Current Challenges and Future Prospects.” The lecture was recorded March 23, 2023, at [More]
Like0000000or copy the linkFred Barrett, Ph.D., Associate Director of the Johns Hopkins Center for Psychedelic & Consciousness Research, discusses “The Cognitive Neuroscience of Psychedelic Drugs.” The lecture was recorded March 23, 2023, at the Psychedelic [More]
Like0000000or copy the linkDr. David Lubarsky, UC Davis Health’s CEO and chancellor of Human Health Sciences, kicks off the 2023 Psychedelic Summit by discussing the promise of psychedelics in medicine. The UC Davis Psychedelic Summit [More]